サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1336506

世界の静脈血栓塞栓症の予防市場：考察と予測 (2029年まで)

Global Venous Thromboembolism Prophylaxis Market Insights, Forecast to 2029
出版日: | 発行: QYResearch | ページ情報: 英文 88 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
世界の静脈血栓塞栓症の予防市場：考察と予測 (2029年まで)
出版日: 2023年08月24日
発行: QYResearch
ページ情報: 英文 88 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、静脈血栓塞栓症の予防 (Venous Thromboembolism Prophylaxis) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • 静脈血栓塞栓症の予防の製品概要
  • 市場：タイプ別
    • 世界の静脈血栓塞栓症の予防の市場規模成長率：タイプ別, 2018 VS 2022 VS 2029
    • Lower Extremity
    • Upper Extremity
  • 市場：用途別
    • 世界の静脈血栓塞栓症の予防の市場規模成長率：用途別, 2018 VS 2022 VS 2029
    • Hospital
    • Clinic
    • Others
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界の静脈血栓塞栓症の予防売上予測・予想 2018-2029
  • 世界の静脈血栓塞栓症の予防の収益：地域別
    • 世界の静脈血栓塞栓症の予防の収益：地域別: 2018 VS 2022 VS 2029
    • 世界の静脈血栓塞栓症の予防の収益：地域別 (2018-2023)
    • 世界の静脈血栓塞栓症の予防の収益：地域別 (2024-2029)
    • 世界の静脈血栓塞栓症の予防の収益市場シェア 地域別 (2018-2029)
  • 世界の静脈血栓塞栓症の予防売上予測・予想 2018-2029
  • 世界の静脈血栓塞栓症の予防の販売：地域別
    • 世界の静脈血栓塞栓症の予防の販売：地域別: 2018 VS 2022 VS 2029
    • 世界の静脈血栓塞栓症の予防の販売：地域別 (2018-2023)
    • 世界の静脈血栓塞栓症の予防の販売：地域別 (2024-2029)
    • 世界の静脈血栓塞栓症の予防の販売市場シェア 地域別 (2018-2029)
  • 米国・カナダ
  • 欧州
  • 中国
  • アジア（中国を除く）
  • 中東, アフリカ ・ラテンアメリカ

第3章 競合：企業別

  • 世界の静脈血栓塞栓症の予防の販売：企業別
    • 世界の静脈血栓塞栓症の予防の販売：企業別 (2018-2023)
    • 世界の静脈血栓塞栓症の予防の販売市場シェア：企業別 (2018-2023)
    • 世界の上位10・上位5企業： 静脈血栓塞栓症の予防 in 2022
  • 世界の静脈血栓塞栓症の予防の収益：企業別
    • 世界の静脈血栓塞栓症の予防の収益：企業別 (2018-2023)
    • 世界の静脈血栓塞栓症の予防の収益市場シェア：企業別 (2018-2023)
    • 世界の上位10・上位5企業： 静脈血栓塞栓症の予防の収益 2022
  • 世界の主要企業 静脈血栓塞栓症の予防, 業界ランキング, 2021 VS 2022 VS 2023
  • 世界の静脈血栓塞栓症の予防の販売価格：企業別
  • 競合情勢の分析
    • 企業の市場集中度 (CR5 and HHI)
    • 世界の静脈血栓塞栓症の予防の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要メーカー 静脈血栓塞栓症の予防, 製造拠点分布と本社
  • 世界の主要メーカー 静脈血栓塞栓症の予防, 提供製品と用途
  • 世界の主要メーカー 静脈血栓塞栓症の予防, 業界参入時期
  • M&A, 拡張計画

第4章 市場規模：タイプ別

  • 世界の静脈血栓塞栓症の予防の販売：タイプ別
    • 世界の静脈血栓塞栓症の予防の販売実績：タイプ別 (2018-2023)
    • 世界の静脈血栓塞栓症の予防の販売予測：タイプ別 (2024-2029)
    • 世界の静脈血栓塞栓症の予防の販売市場シェア：タイプ別 (2018-2029)
  • 世界の静脈血栓塞栓症の予防 収益：タイプ別
    • 世界の静脈血栓塞栓症の予防の収益実績：タイプ別 (2018-2023)
    • 世界の静脈血栓塞栓症の予防の収益予測：タイプ別 (2024-2029)
    • 世界の静脈血栓塞栓症の予防の収益市場シェア：タイプ別 (2018-2029)
  • 世界の静脈血栓塞栓症の予防の価格：タイプ別
    • 世界の静脈血栓塞栓症の予防の価格：タイプ別 (2018-2023)
    • 世界の静脈血栓塞栓症の予防の価格予測：タイプ別 (2024-2029)

第5章 市場規模：用途別

  • 世界の静脈血栓塞栓症の予防の販売：用途別
    • 世界の静脈血栓塞栓症の予防の販売実績：用途別 (2018-2023)
    • 世界の静脈血栓塞栓症の予防の販売予測：用途別 (2024-2029)
    • 世界の静脈血栓塞栓症の予防の販売市場シェア：用途別 (2018-2029)
  • 世界の静脈血栓塞栓症の予防の収益：用途別
    • 世界の静脈血栓塞栓症の予防の収益実績：用途別 (2018-2023)
    • 世界の静脈血栓塞栓症の予防の収益予測：用途別 (2024-2029)
    • 世界の静脈血栓塞栓症の予防の収益市場シェア：用途別 (2018-2029)
  • 世界の静脈血栓塞栓症の予防の価格：用途別
    • 世界の静脈血栓塞栓症の予防の価格：用途別 (2018-2023)
    • 世界の静脈血栓塞栓症の予防の価格予測：用途別 (2024-2029)

第6章 米国・カナダ

  • 米国・カナダ 静脈血栓塞栓症の予防 市場規模：タイプ別
    • 米国・カナダ 静脈血栓塞栓症の予防の販売：タイプ別 (2018-2029)
    • 米国・カナダ 静脈血栓塞栓症の予防 収益：タイプ別 (2018-2029)
  • 米国・カナダ 静脈血栓塞栓症の予防 市場規模：用途別
    • 米国・カナダ 静脈血栓塞栓症の予防の販売：用途別 (2018-2029)
    • 米国・カナダ 静脈血栓塞栓症の予防の収益：用途別 (2018-2029)
  • 米国・カナダ 静脈血栓塞栓症の予防 市場規模：国別
    • 米国・カナダ 静脈血栓塞栓症の予防の収益：国別: 2018 VS 2022 VS 2029
    • 米国・カナダ 静脈血栓塞栓症の予防の販売：国別 (2018-2029)
    • 米国・カナダ 静脈血栓塞栓症の予防の収益：国別 (2018-2029)
    • US
    • カナダ

第7章 欧州

  • 欧州の静脈血栓塞栓症の予防 市場規模：タイプ別
    • 欧州の静脈血栓塞栓症の予防の販売：タイプ別 (2018-2029)
    • 欧州の静脈血栓塞栓症の予防 収益：タイプ別 (2018-2029)
  • 欧州の静脈血栓塞栓症の予防 市場規模：用途別
    • 欧州の静脈血栓塞栓症の予防の販売：用途別 (2018-2029)
    • 欧州の静脈血栓塞栓症の予防の収益：用途別 (2018-2029)
  • 欧州の静脈血栓塞栓症の予防 市場規模：国別
    • 欧州の静脈血栓塞栓症の予防の収益：国別: 2018 VS 2022 VS 2029
    • 欧州の静脈血栓塞栓症の予防の販売：国別 (2018-2029)
    • 欧州の静脈血栓塞栓症の予防の収益：国別 (2018-2029)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 中国

  • 中国の静脈血栓塞栓症の予防 市場規模
    • 中国の静脈血栓塞栓症の予防 売上 (2018-2029)
    • 中国の静脈血栓塞栓症の予防 収益 (2018-2029)
  • 中国の静脈血栓塞栓症の予防 市場規模：用途別
    • 中国の静脈血栓塞栓症の予防の販売：用途別 (2018-2029)
    • 中国の静脈血栓塞栓症の予防の収益：用途別 (2018-2029)

第9章 アジア（中国を除く）

  • アジア地域 静脈血栓塞栓症の予防 市場規模：タイプ別
    • アジア地域 静脈血栓塞栓症の予防の販売：タイプ別 (2018-2029)
    • アジア地域 静脈血栓塞栓症の予防 収益：タイプ別 (2018-2029)
  • アジア地域 静脈血栓塞栓症の予防 市場規模：用途別
    • アジア地域 静脈血栓塞栓症の予防の販売：用途別 (2018-2029)
    • アジア地域 静脈血栓塞栓症の予防の収益：用途別 (2018-2029)
  • アジア地域 静脈血栓塞栓症の予防の販売：地域別
    • アジア地域 静脈血栓塞栓症の予防の収益：地域別: 2018 VS 2022 VS 2029
    • アジア地域 静脈血栓塞栓症の予防の収益：地域別 (2018-2029)
    • アジア地域 静脈血栓塞栓症の予防の販売：地域別 (2018-2029)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド

第10章 中東, アフリカ ・ラテンアメリカ

  • 中東, アフリカ ・ラテンアメリカの静脈血栓塞栓症の予防 市場規模：タイプ別
    • 中東, アフリカ ・ラテンアメリカの静脈血栓塞栓症の予防の販売：タイプ別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカの静脈血栓塞栓症の予防 収益：タイプ別 (2018-2029)
  • 中東, アフリカ ・ラテンアメリカの静脈血栓塞栓症の予防 市場規模：用途別
    • 中東, アフリカ ・ラテンアメリカの静脈血栓塞栓症の予防の販売：用途別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカの静脈血栓塞栓症の予防の収益：用途別 (2018-2029)
  • 中東, アフリカ ・ラテンアメリカの静脈血栓塞栓症の予防の販売：国別
    • 中東, アフリカ ・ラテンアメリカの静脈血栓塞栓症の予防の収益：国別: 2018 VS 2022 VS 2029
    • 中東, アフリカ ・ラテンアメリカの静脈血栓塞栓症の予防の収益：国別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカの静脈血栓塞栓症の予防の販売：国別 (2018-2029)
    • ブラジル
    • メキシコ
    • トルコ
    • イスラエル
    • 湾岸協力理事会諸国

第11章 企業プロファイル

  • Arjo
  • Encompass Group
  • Talley Group
  • MEGO AFEK
  • Zenith Technical Innovations
  • Normatec
  • Bio Compression Systems
  • ThermoTek USA

第12章 業界チェーンと販売チャネルの分析

  • 静脈血栓塞栓症の予防 業界チェーン分析
  • 静脈血栓塞栓症の予防 主要原材料
    • 主要原材料
    • 原材料の主要サプライヤー
  • 静脈血栓塞栓症の予防 生産形態とプロセス
  • 静脈血栓塞栓症の予防 販売およびマーケティング
    • 静脈血栓塞栓症の予防 販売チャネル
    • 静脈血栓塞栓症の予防 卸業者
  • 静脈血栓塞栓症の予防 顧客

第13章 市場動向

  • 静脈血栓塞栓症の予防 業界動向
  • 静脈血栓塞栓症の予防 市場の促進要因
  • 静脈血栓塞栓症の予防 市場の課題
  • 静脈血栓塞栓症の予防 市場の抑制要因

第14章 主な調査結果 世界の静脈血栓塞栓症の予防の主な市場調査結果

第15章 付録

図表

List of Tables

  • Table 1. Global Venous Thromboembolism Prophylaxis Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 2. Major Manufacturers of Lower Extremity
  • Table 3. Major Manufacturers of Upper Extremity
  • Table 4. Global Venous Thromboembolism Prophylaxis Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 5. Global Venous Thromboembolism Prophylaxis Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 6. Global Venous Thromboembolism Prophylaxis Revenue by Region (2018-2023) & (US$ Million)
  • Table 7. Global Venous Thromboembolism Prophylaxis Revenue by Region (2024-2029) & (US$ Million)
  • Table 8. Global Venous Thromboembolism Prophylaxis Revenue Market Share by Region (2018-2023)
  • Table 9. Global Venous Thromboembolism Prophylaxis Revenue Market Share by Region (2024-2029)
  • Table 10. Global Venous Thromboembolism Prophylaxis Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 11. Global Venous Thromboembolism Prophylaxis Sales by Region (2018-2023) & (K Units)
  • Table 12. Global Venous Thromboembolism Prophylaxis Sales by Region (2024-2029) & (K Units)
  • Table 13. Global Venous Thromboembolism Prophylaxis Sales Market Share by Region (2018-2023)
  • Table 14. Global Venous Thromboembolism Prophylaxis Sales Market Share by Region (2024-2029)
  • Table 15. Global Venous Thromboembolism Prophylaxis Sales by Manufacturers (2018-2023) & (K Units)
  • Table 16. Global Venous Thromboembolism Prophylaxis Sales Share by Manufacturers (2018-2023)
  • Table 17. Global Venous Thromboembolism Prophylaxis Revenue by Manufacturers (2018-2023) & (US$ Million)
  • Table 18. Global Venous Thromboembolism Prophylaxis Revenue Share by Manufacturers (2018-2023)
  • Table 19. Global Key Players of Venous Thromboembolism Prophylaxis, Industry Ranking, 2021 VS 2022 VS 2023
  • Table 20. Venous Thromboembolism Prophylaxis Price by Manufacturers 2018-2023 (US$/Unit)
  • Table 21. Global Venous Thromboembolism Prophylaxis Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 22. Global Venous Thromboembolism Prophylaxis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Venous Thromboembolism Prophylaxis as of 2022)
  • Table 23. Global Key Manufacturers of Venous Thromboembolism Prophylaxis, Manufacturing Base Distribution and Headquarters
  • Table 24. Global Key Manufacturers of Venous Thromboembolism Prophylaxis, Product Offered and Application
  • Table 25. Global Key Manufacturers of Venous Thromboembolism Prophylaxis, Date of Enter into This Industry
  • Table 26. Mergers & Acquisitions, Expansion Plans
  • Table 27. Global Venous Thromboembolism Prophylaxis Sales by Type (2018-2023) & (K Units)
  • Table 28. Global Venous Thromboembolism Prophylaxis Sales by Type (2024-2029) & (K Units)
  • Table 29. Global Venous Thromboembolism Prophylaxis Sales Share by Type (2018-2023)
  • Table 30. Global Venous Thromboembolism Prophylaxis Sales Share by Type (2024-2029)
  • Table 31. Global Venous Thromboembolism Prophylaxis Revenue by Type (2018-2023) & (US$ Million)
  • Table 32. Global Venous Thromboembolism Prophylaxis Revenue by Type (2024-2029) & (US$ Million)
  • Table 33. Global Venous Thromboembolism Prophylaxis Revenue Share by Type (2018-2023)
  • Table 34. Global Venous Thromboembolism Prophylaxis Revenue Share by Type (2024-2029)
  • Table 35. Venous Thromboembolism Prophylaxis Price by Type (2018-2023) & (US$/Unit)
  • Table 36. Global Venous Thromboembolism Prophylaxis Price Forecast by Type (2024-2029) & (US$/Unit)
  • Table 37. Global Venous Thromboembolism Prophylaxis Sales by Application (2018-2023) & (K Units)
  • Table 38. Global Venous Thromboembolism Prophylaxis Sales by Application (2024-2029) & (K Units)
  • Table 39. Global Venous Thromboembolism Prophylaxis Sales Share by Application (2018-2023)
  • Table 40. Global Venous Thromboembolism Prophylaxis Sales Share by Application (2024-2029)
  • Table 41. Global Venous Thromboembolism Prophylaxis Revenue by Application (2018-2023) & (US$ Million)
  • Table 42. Global Venous Thromboembolism Prophylaxis Revenue by Application (2024-2029) & (US$ Million)
  • Table 43. Global Venous Thromboembolism Prophylaxis Revenue Share by Application (2018-2023)
  • Table 44. Global Venous Thromboembolism Prophylaxis Revenue Share by Application (2024-2029)
  • Table 45. Venous Thromboembolism Prophylaxis Price by Application (2018-2023) & (US$/Unit)
  • Table 46. Global Venous Thromboembolism Prophylaxis Price Forecast by Application (2024-2029) & (US$/Unit)
  • Table 47. US & Canada Venous Thromboembolism Prophylaxis Sales by Type (2018-2023) & (K Units)
  • Table 48. US & Canada Venous Thromboembolism Prophylaxis Sales by Type (2024-2029) & (K Units)
  • Table 49. US & Canada Venous Thromboembolism Prophylaxis Revenue by Type (2018-2023) & (US$ Million)
  • Table 50. US & Canada Venous Thromboembolism Prophylaxis Revenue by Type (2024-2029) & (US$ Million)
  • Table 51. US & Canada Venous Thromboembolism Prophylaxis Sales by Application (2018-2023) & (K Units)
  • Table 52. US & Canada Venous Thromboembolism Prophylaxis Sales by Application (2024-2029) & (K Units)
  • Table 53. US & Canada Venous Thromboembolism Prophylaxis Revenue by Application (2018-2023) & (US$ Million)
  • Table 54. US & Canada Venous Thromboembolism Prophylaxis Revenue by Application (2024-2029) & (US$ Million)
  • Table 55. US & Canada Venous Thromboembolism Prophylaxis Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 56. US & Canada Venous Thromboembolism Prophylaxis Revenue by Country (2018-2023) & (US$ Million)
  • Table 57. US & Canada Venous Thromboembolism Prophylaxis Revenue by Country (2024-2029) & (US$ Million)
  • Table 58. US & Canada Venous Thromboembolism Prophylaxis Sales by Country (2018-2023) & (K Units)
  • Table 59. US & Canada Venous Thromboembolism Prophylaxis Sales by Country (2024-2029) & (K Units)
  • Table 60. Europe Venous Thromboembolism Prophylaxis Sales by Type (2018-2023) & (K Units)
  • Table 61. Europe Venous Thromboembolism Prophylaxis Sales by Type (2024-2029) & (K Units)
  • Table 62. Europe Venous Thromboembolism Prophylaxis Revenue by Type (2018-2023) & (US$ Million)
  • Table 63. Europe Venous Thromboembolism Prophylaxis Revenue by Type (2024-2029) & (US$ Million)
  • Table 64. Europe Venous Thromboembolism Prophylaxis Sales by Application (2018-2023) & (K Units)
  • Table 65. Europe Venous Thromboembolism Prophylaxis Sales by Application (2024-2029) & (K Units)
  • Table 66. Europe Venous Thromboembolism Prophylaxis Revenue by Application (2018-2023) & (US$ Million)
  • Table 67. Europe Venous Thromboembolism Prophylaxis Revenue by Application (2024-2029) & (US$ Million)
  • Table 68. Europe Venous Thromboembolism Prophylaxis Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 69. Europe Venous Thromboembolism Prophylaxis Revenue by Country (2018-2023) & (US$ Million)
  • Table 70. Europe Venous Thromboembolism Prophylaxis Revenue by Country (2024-2029) & (US$ Million)
  • Table 71. Europe Venous Thromboembolism Prophylaxis Sales by Country (2018-2023) & (K Units)
  • Table 72. Europe Venous Thromboembolism Prophylaxis Sales by Country (2024-2029) & (K Units)
  • Table 73. China Venous Thromboembolism Prophylaxis Sales by Type (2018-2023) & (K Units)
  • Table 74. China Venous Thromboembolism Prophylaxis Sales by Type (2024-2029) & (K Units)
  • Table 75. China Venous Thromboembolism Prophylaxis Revenue by Type (2018-2023) & (US$ Million)
  • Table 76. China Venous Thromboembolism Prophylaxis Revenue by Type (2024-2029) & (US$ Million)
  • Table 77. China Venous Thromboembolism Prophylaxis Sales by Application (2018-2023) & (K Units)
  • Table 78. China Venous Thromboembolism Prophylaxis Sales by Application (2024-2029) & (K Units)
  • Table 79. China Venous Thromboembolism Prophylaxis Revenue by Application (2018-2023) & (US$ Million)
  • Table 80. China Venous Thromboembolism Prophylaxis Revenue by Application (2024-2029) & (US$ Million)
  • Table 81. Asia Venous Thromboembolism Prophylaxis Sales by Type (2018-2023) & (K Units)
  • Table 82. Asia Venous Thromboembolism Prophylaxis Sales by Type (2024-2029) & (K Units)
  • Table 83. Asia Venous Thromboembolism Prophylaxis Revenue by Type (2018-2023) & (US$ Million)
  • Table 84. Asia Venous Thromboembolism Prophylaxis Revenue by Type (2024-2029) & (US$ Million)
  • Table 85. Asia Venous Thromboembolism Prophylaxis Sales by Application (2018-2023) & (K Units)
  • Table 86. Asia Venous Thromboembolism Prophylaxis Sales by Application (2024-2029) & (K Units)
  • Table 87. Asia Venous Thromboembolism Prophylaxis Revenue by Application (2018-2023) & (US$ Million)
  • Table 88. Asia Venous Thromboembolism Prophylaxis Revenue by Application (2024-2029) & (US$ Million)
  • Table 89. Asia Venous Thromboembolism Prophylaxis Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 90. Asia Venous Thromboembolism Prophylaxis Revenue by Region (2018-2023) & (US$ Million)
  • Table 91. Asia Venous Thromboembolism Prophylaxis Revenue by Region (2024-2029) & (US$ Million)
  • Table 92. Asia Venous Thromboembolism Prophylaxis Sales by Region (2018-2023) & (K Units)
  • Table 93. Asia Venous Thromboembolism Prophylaxis Sales by Region (2024-2029) & (K Units)
  • Table 94. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Sales by Type (2018-2023) & (K Units)
  • Table 95. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Sales by Type (2024-2029) & (K Units)
  • Table 96. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue by Type (2018-2023) & (US$ Million)
  • Table 97. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue by Type (2024-2029) & (US$ Million)
  • Table 98. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Sales by Application (2018-2023) & (K Units)
  • Table 99. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Sales by Application (2024-2029) & (K Units)
  • Table 100. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue by Application (2018-2023) & (US$ Million)
  • Table 101. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue by Application (2024-2029) & (US$ Million)
  • Table 102. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 103. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue by Country (2018-2023) & (US$ Million)
  • Table 104. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue by Country (2024-2029) & (US$ Million)
  • Table 105. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Sales by Country (2018-2023) & (K Units)
  • Table 106. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Sales by Country (2024-2029) & (K Units)
  • Table 107. Arjo Company Information
  • Table 108. Arjo Description and Major Businesses
  • Table 109. Arjo Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 110. Arjo Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 111. Arjo Recent Developments
  • Table 112. Encompass Group Company Information
  • Table 113. Encompass Group Description and Major Businesses
  • Table 114. Encompass Group Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 115. Encompass Group Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 116. Encompass Group Recent Developments
  • Table 117. Talley Group Company Information
  • Table 118. Talley Group Description and Major Businesses
  • Table 119. Talley Group Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 120. Talley Group Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 121. Talley Group Recent Developments
  • Table 122. MEGO AFEK Company Information
  • Table 123. MEGO AFEK Description and Major Businesses
  • Table 124. MEGO AFEK Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 125. MEGO AFEK Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 126. MEGO AFEK Recent Developments
  • Table 127. Zenith Technical Innovations Company Information
  • Table 128. Zenith Technical Innovations Description and Major Businesses
  • Table 129. Zenith Technical Innovations Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 130. Zenith Technical Innovations Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 131. Zenith Technical Innovations Recent Developments
  • Table 132. Normatec Company Information
  • Table 133. Normatec Description and Major Businesses
  • Table 134. Normatec Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 135. Normatec Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 136. Normatec Recent Developments
  • Table 137. Bio Compression Systems Company Information
  • Table 138. Bio Compression Systems Description and Major Businesses
  • Table 139. Bio Compression Systems Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 140. Bio Compression Systems Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 141. Bio Compression Systems Recent Developments
  • Table 142. ThermoTek USA Company Information
  • Table 143. ThermoTek USA Description and Major Businesses
  • Table 144. ThermoTek USA Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 145. ThermoTek USA Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 146. ThermoTek USA Recent Developments
  • Table 147. Key Raw Materials Lists
  • Table 148. Raw Materials Key Suppliers Lists
  • Table 149. Venous Thromboembolism Prophylaxis Distributors List
  • Table 150. Venous Thromboembolism Prophylaxis Customers List
  • Table 151. Venous Thromboembolism Prophylaxis Market Trends
  • Table 152. Venous Thromboembolism Prophylaxis Market Drivers
  • Table 153. Venous Thromboembolism Prophylaxis Market Challenges
  • Table 154. Venous Thromboembolism Prophylaxis Market Restraints
  • Table 155. Research Programs/Design for This Report
  • Table 156. Key Data Information from Secondary Sources
  • Table 157. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Venous Thromboembolism Prophylaxis Product Picture
  • Figure 2. Global Venous Thromboembolism Prophylaxis Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 3. Global Venous Thromboembolism Prophylaxis Market Share by Type in 2022 & 2029
  • Figure 4. Lower Extremity Product Picture
  • Figure 5. Upper Extremity Product Picture
  • Figure 6. Global Venous Thromboembolism Prophylaxis Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 7. Global Venous Thromboembolism Prophylaxis Market Share by Application in 2022 & 2029
  • Figure 8. Hospital
  • Figure 9. Clinic
  • Figure 10. Others
  • Figure 11. Venous Thromboembolism Prophylaxis Report Years Considered
  • Figure 12. Global Venous Thromboembolism Prophylaxis Revenue, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 13. Global Venous Thromboembolism Prophylaxis Revenue 2018-2029 (US$ Million)
  • Figure 14. Global Venous Thromboembolism Prophylaxis Revenue Market Share by Region in Percentage: 2022 Versus 2029
  • Figure 15. Global Venous Thromboembolism Prophylaxis Revenue Market Share by Region (2018-2029)
  • Figure 16. Global Venous Thromboembolism Prophylaxis Sales 2018-2029 ((K Units)
  • Figure 17. Global Venous Thromboembolism Prophylaxis Sales Market Share by Region (2018-2029)
  • Figure 18. US & Canada Venous Thromboembolism Prophylaxis Sales YoY (2018-2029) & (K Units)
  • Figure 19. US & Canada Venous Thromboembolism Prophylaxis Revenue YoY (2018-2029) & (US$ Million)
  • Figure 20. Europe Venous Thromboembolism Prophylaxis Sales YoY (2018-2029) & (K Units)
  • Figure 21. Europe Venous Thromboembolism Prophylaxis Revenue YoY (2018-2029) & (US$ Million)
  • Figure 22. China Venous Thromboembolism Prophylaxis Sales YoY (2018-2029) & (K Units)
  • Figure 23. China Venous Thromboembolism Prophylaxis Revenue YoY (2018-2029) & (US$ Million)
  • Figure 24. Asia (excluding China) Venous Thromboembolism Prophylaxis Sales YoY (2018-2029) & (K Units)
  • Figure 25. Asia (excluding China) Venous Thromboembolism Prophylaxis Revenue YoY (2018-2029) & (US$ Million)
  • Figure 26. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Sales YoY (2018-2029) & (K Units)
  • Figure 27. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue YoY (2018-2029) & (US$ Million)
  • Figure 28. The Venous Thromboembolism Prophylaxis Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
  • Figure 29. The Top 5 and 10 Largest Manufacturers of Venous Thromboembolism Prophylaxis in the World: Market Share by Venous Thromboembolism Prophylaxis Revenue in 2022
  • Figure 30. Global Venous Thromboembolism Prophylaxis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
  • Figure 31. Global Venous Thromboembolism Prophylaxis Sales Market Share by Type (2018-2029)
  • Figure 32. Global Venous Thromboembolism Prophylaxis Revenue Market Share by Type (2018-2029)
  • Figure 33. Global Venous Thromboembolism Prophylaxis Sales Market Share by Application (2018-2029)
  • Figure 34. Global Venous Thromboembolism Prophylaxis Revenue Market Share by Application (2018-2029)
  • Figure 35. US & Canada Venous Thromboembolism Prophylaxis Sales Market Share by Type (2018-2029)
  • Figure 36. US & Canada Venous Thromboembolism Prophylaxis Revenue Market Share by Type (2018-2029)
  • Figure 37. US & Canada Venous Thromboembolism Prophylaxis Sales Market Share by Application (2018-2029)
  • Figure 38. US & Canada Venous Thromboembolism Prophylaxis Revenue Market Share by Application (2018-2029)
  • Figure 39. US & Canada Venous Thromboembolism Prophylaxis Revenue Share by Country (2018-2029)
  • Figure 40. US & Canada Venous Thromboembolism Prophylaxis Sales Share by Country (2018-2029)
  • Figure 41. U.S. Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
  • Figure 42. Canada Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
  • Figure 43. Europe Venous Thromboembolism Prophylaxis Sales Market Share by Type (2018-2029)
  • Figure 44. Europe Venous Thromboembolism Prophylaxis Revenue Market Share by Type (2018-2029)
  • Figure 45. Europe Venous Thromboembolism Prophylaxis Sales Market Share by Application (2018-2029)
  • Figure 46. Europe Venous Thromboembolism Prophylaxis Revenue Market Share by Application (2018-2029)
  • Figure 47. Europe Venous Thromboembolism Prophylaxis Revenue Share by Country (2018-2029)
  • Figure 48. Europe Venous Thromboembolism Prophylaxis Sales Share by Country (2018-2029)
  • Figure 49. Germany Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
  • Figure 50. France Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
  • Figure 51. U.K. Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
  • Figure 52. Italy Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
  • Figure 53. Russia Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
  • Figure 54. China Venous Thromboembolism Prophylaxis Sales Market Share by Type (2018-2029)
  • Figure 55. China Venous Thromboembolism Prophylaxis Revenue Market Share by Type (2018-2029)
  • Figure 56. China Venous Thromboembolism Prophylaxis Sales Market Share by Application (2018-2029)
  • Figure 57. China Venous Thromboembolism Prophylaxis Revenue Market Share by Application (2018-2029)
  • Figure 58. Asia Venous Thromboembolism Prophylaxis Sales Market Share by Type (2018-2029)
  • Figure 59. Asia Venous Thromboembolism Prophylaxis Revenue Market Share by Type (2018-2029)
  • Figure 60. Asia Venous Thromboembolism Prophylaxis Sales Market Share by Application (2018-2029)
  • Figure 61. Asia Venous Thromboembolism Prophylaxis Revenue Market Share by Application (2018-2029)
  • Figure 62. Asia Venous Thromboembolism Prophylaxis Revenue Share by Region (2018-2029)
  • Figure 63. Asia Venous Thromboembolism Prophylaxis Sales Share by Region (2018-2029)
  • Figure 64. Japan Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
  • Figure 65. South Korea Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
  • Figure 66. China Taiwan Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
  • Figure 67. Southeast Asia Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
  • Figure 68. India Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
  • Figure 69. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Sales Market Share by Type (2018-2029)
  • Figure 70. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue Market Share by Type (2018-2029)
  • Figure 71. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Sales Market Share by Application (2018-2029)
  • Figure 72. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue Market Share by Application (2018-2029)
  • Figure 73. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue Share by Country (2018-2029)
  • Figure 74. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Sales Share by Country (2018-2029)
  • Figure 75. Brazil Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
  • Figure 76. Mexico Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
  • Figure 77. Turkey Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
  • Figure 78. Israel Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
  • Figure 79. GCC Countries Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
  • Figure 80. Venous Thromboembolism Prophylaxis Value Chain
  • Figure 81. Venous Thromboembolism Prophylaxis Production Process
  • Figure 82. Channels of Distribution
  • Figure 83. Distributors Profiles
  • Figure 84. Bottom-up and Top-down Approaches for This Report
  • Figure 85. Data Triangulation
  • Figure 86. Key Executives Interviewed
目次

This research report focuses on the Venous Thromboembolism Prophylaxis Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Venous Thromboembolism Prophylaxis Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Venous Thromboembolism Prophylaxis Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Lower Extremity
    • 1.2.3 Upper Extremity
  • 1.3 Market by Application
    • 1.3.1 Global Venous Thromboembolism Prophylaxis Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Hospital
    • 1.3.3 Clinic
    • 1.3.4 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Executive Summary

  • 2.1 Global Venous Thromboembolism Prophylaxis Sales Estimates and Forecasts 2018-2029
  • 2.2 Global Venous Thromboembolism Prophylaxis Revenue by Region
    • 2.2.1 Global Venous Thromboembolism Prophylaxis Revenue by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Global Venous Thromboembolism Prophylaxis Revenue by Region (2018-2023)
    • 2.2.3 Global Venous Thromboembolism Prophylaxis Revenue by Region (2024-2029)
    • 2.2.4 Global Venous Thromboembolism Prophylaxis Revenue Market Share by Region (2018-2029)
  • 2.3 Global Venous Thromboembolism Prophylaxis Sales Estimates and Forecasts 2018-2029
  • 2.4 Global Venous Thromboembolism Prophylaxis Sales by Region
    • 2.4.1 Global Venous Thromboembolism Prophylaxis Sales by Region: 2018 VS 2022 VS 2029
    • 2.4.2 Global Venous Thromboembolism Prophylaxis Sales by Region (2018-2023)
    • 2.4.3 Global Venous Thromboembolism Prophylaxis Sales by Region (2024-2029)
    • 2.4.4 Global Venous Thromboembolism Prophylaxis Sales Market Share by Region (2018-2029)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 China
  • 2.8 Asia (excluding China)
  • 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

  • 3.1 Global Venous Thromboembolism Prophylaxis Sales by Manufacturers
    • 3.1.1 Global Venous Thromboembolism Prophylaxis Sales by Manufacturers (2018-2023)
    • 3.1.2 Global Venous Thromboembolism Prophylaxis Sales Market Share by Manufacturers (2018-2023)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Venous Thromboembolism Prophylaxis in 2022
  • 3.2 Global Venous Thromboembolism Prophylaxis Revenue by Manufacturers
    • 3.2.1 Global Venous Thromboembolism Prophylaxis Revenue by Manufacturers (2018-2023)
    • 3.2.2 Global Venous Thromboembolism Prophylaxis Revenue Market Share by Manufacturers (2018-2023)
    • 3.2.3 Global Top 10 and Top 5 Companies by Venous Thromboembolism Prophylaxis Revenue in 2022
  • 3.3 Global Key Players of Venous Thromboembolism Prophylaxis, Industry Ranking, 2021 VS 2022 VS 2023
  • 3.4 Global Venous Thromboembolism Prophylaxis Sales Price by Manufacturers
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global Venous Thromboembolism Prophylaxis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of Venous Thromboembolism Prophylaxis, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of Venous Thromboembolism Prophylaxis, Product Offered and Application
  • 3.8 Global Key Manufacturers of Venous Thromboembolism Prophylaxis, Date of Enter into This Industry
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Venous Thromboembolism Prophylaxis Sales by Type
    • 4.1.1 Global Venous Thromboembolism Prophylaxis Historical Sales by Type (2018-2023)
    • 4.1.2 Global Venous Thromboembolism Prophylaxis Forecasted Sales by Type (2024-2029)
    • 4.1.3 Global Venous Thromboembolism Prophylaxis Sales Market Share by Type (2018-2029)
  • 4.2 Global Venous Thromboembolism Prophylaxis Revenue by Type
    • 4.2.1 Global Venous Thromboembolism Prophylaxis Historical Revenue by Type (2018-2023)
    • 4.2.2 Global Venous Thromboembolism Prophylaxis Forecasted Revenue by Type (2024-2029)
    • 4.2.3 Global Venous Thromboembolism Prophylaxis Revenue Market Share by Type (2018-2029)
  • 4.3 Global Venous Thromboembolism Prophylaxis Price by Type
    • 4.3.1 Global Venous Thromboembolism Prophylaxis Price by Type (2018-2023)
    • 4.3.2 Global Venous Thromboembolism Prophylaxis Price Forecast by Type (2024-2029)

5 Market Size by Application

  • 5.1 Global Venous Thromboembolism Prophylaxis Sales by Application
    • 5.1.1 Global Venous Thromboembolism Prophylaxis Historical Sales by Application (2018-2023)
    • 5.1.2 Global Venous Thromboembolism Prophylaxis Forecasted Sales by Application (2024-2029)
    • 5.1.3 Global Venous Thromboembolism Prophylaxis Sales Market Share by Application (2018-2029)
  • 5.2 Global Venous Thromboembolism Prophylaxis Revenue by Application
    • 5.2.1 Global Venous Thromboembolism Prophylaxis Historical Revenue by Application (2018-2023)
    • 5.2.2 Global Venous Thromboembolism Prophylaxis Forecasted Revenue by Application (2024-2029)
    • 5.2.3 Global Venous Thromboembolism Prophylaxis Revenue Market Share by Application (2018-2029)
  • 5.3 Global Venous Thromboembolism Prophylaxis Price by Application
    • 5.3.1 Global Venous Thromboembolism Prophylaxis Price by Application (2018-2023)
    • 5.3.2 Global Venous Thromboembolism Prophylaxis Price Forecast by Application (2024-2029)

6 US & Canada

  • 6.1 US & Canada Venous Thromboembolism Prophylaxis Market Size by Type
    • 6.1.1 US & Canada Venous Thromboembolism Prophylaxis Sales by Type (2018-2029)
    • 6.1.2 US & Canada Venous Thromboembolism Prophylaxis Revenue by Type (2018-2029)
  • 6.2 US & Canada Venous Thromboembolism Prophylaxis Market Size by Application
    • 6.2.1 US & Canada Venous Thromboembolism Prophylaxis Sales by Application (2018-2029)
    • 6.2.2 US & Canada Venous Thromboembolism Prophylaxis Revenue by Application (2018-2029)
  • 6.3 US & Canada Venous Thromboembolism Prophylaxis Market Size by Country
    • 6.3.1 US & Canada Venous Thromboembolism Prophylaxis Revenue by Country: 2018 VS 2022 VS 2029
    • 6.3.2 US & Canada Venous Thromboembolism Prophylaxis Sales by Country (2018-2029)
    • 6.3.3 US & Canada Venous Thromboembolism Prophylaxis Revenue by Country (2018-2029)
    • 6.3.4 US
    • 6.3.5 Canada

7 Europe

  • 7.1 Europe Venous Thromboembolism Prophylaxis Market Size by Type
    • 7.1.1 Europe Venous Thromboembolism Prophylaxis Sales by Type (2018-2029)
    • 7.1.2 Europe Venous Thromboembolism Prophylaxis Revenue by Type (2018-2029)
  • 7.2 Europe Venous Thromboembolism Prophylaxis Market Size by Application
    • 7.2.1 Europe Venous Thromboembolism Prophylaxis Sales by Application (2018-2029)
    • 7.2.2 Europe Venous Thromboembolism Prophylaxis Revenue by Application (2018-2029)
  • 7.3 Europe Venous Thromboembolism Prophylaxis Market Size by Country
    • 7.3.1 Europe Venous Thromboembolism Prophylaxis Revenue by Country: 2018 VS 2022 VS 2029
    • 7.3.2 Europe Venous Thromboembolism Prophylaxis Sales by Country (2018-2029)
    • 7.3.3 Europe Venous Thromboembolism Prophylaxis Revenue by Country (2018-2029)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 U.K.
    • 7.3.7 Italy
    • 7.3.8 Russia

8 China

  • 8.1 China Venous Thromboembolism Prophylaxis Market Size
    • 8.1.1 China Venous Thromboembolism Prophylaxis Sales (2018-2029)
    • 8.1.2 China Venous Thromboembolism Prophylaxis Revenue (2018-2029)
  • 8.2 China Venous Thromboembolism Prophylaxis Market Size by Application
    • 8.2.1 China Venous Thromboembolism Prophylaxis Sales by Application (2018-2029)
    • 8.2.2 China Venous Thromboembolism Prophylaxis Revenue by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Venous Thromboembolism Prophylaxis Market Size by Type
    • 9.1.1 Asia Venous Thromboembolism Prophylaxis Sales by Type (2018-2029)
    • 9.1.2 Asia Venous Thromboembolism Prophylaxis Revenue by Type (2018-2029)
  • 9.2 Asia Venous Thromboembolism Prophylaxis Market Size by Application
    • 9.2.1 Asia Venous Thromboembolism Prophylaxis Sales by Application (2018-2029)
    • 9.2.2 Asia Venous Thromboembolism Prophylaxis Revenue by Application (2018-2029)
  • 9.3 Asia Venous Thromboembolism Prophylaxis Sales by Region
    • 9.3.1 Asia Venous Thromboembolism Prophylaxis Revenue by Region: 2018 VS 2022 VS 2029
    • 9.3.2 Asia Venous Thromboembolism Prophylaxis Revenue by Region (2018-2029)
    • 9.3.3 Asia Venous Thromboembolism Prophylaxis Sales by Region (2018-2029)
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 China Taiwan
    • 9.3.7 Southeast Asia
    • 9.3.8 India

10 Middle East, Africa and Latin America

  • 10.1 Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Market Size by Type
    • 10.1.1 Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Sales by Type (2018-2029)
    • 10.1.2 Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue by Type (2018-2029)
  • 10.2 Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Market Size by Application
    • 10.2.1 Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Sales by Application (2018-2029)
    • 10.2.2 Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue by Application (2018-2029)
  • 10.3 Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Sales by Country
    • 10.3.1 Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue by Country: 2018 VS 2022 VS 2029
    • 10.3.2 Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue by Country (2018-2029)
    • 10.3.3 Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Sales by Country (2018-2029)
    • 10.3.4 Brazil
    • 10.3.5 Mexico
    • 10.3.6 Turkey
    • 10.3.7 Israel
    • 10.3.8 GCC Countries

11 Company Profiles

  • 11.1 Arjo
    • 11.1.1 Arjo Company Information
    • 11.1.2 Arjo Overview
    • 11.1.3 Arjo Venous Thromboembolism Prophylaxis Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.1.4 Arjo Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Arjo Recent Developments
  • 11.2 Encompass Group
    • 11.2.1 Encompass Group Company Information
    • 11.2.2 Encompass Group Overview
    • 11.2.3 Encompass Group Venous Thromboembolism Prophylaxis Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.2.4 Encompass Group Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Encompass Group Recent Developments
  • 11.3 Talley Group
    • 11.3.1 Talley Group Company Information
    • 11.3.2 Talley Group Overview
    • 11.3.3 Talley Group Venous Thromboembolism Prophylaxis Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.3.4 Talley Group Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Talley Group Recent Developments
  • 11.4 MEGO AFEK
    • 11.4.1 MEGO AFEK Company Information
    • 11.4.2 MEGO AFEK Overview
    • 11.4.3 MEGO AFEK Venous Thromboembolism Prophylaxis Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.4.4 MEGO AFEK Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 MEGO AFEK Recent Developments
  • 11.5 Zenith Technical Innovations
    • 11.5.1 Zenith Technical Innovations Company Information
    • 11.5.2 Zenith Technical Innovations Overview
    • 11.5.3 Zenith Technical Innovations Venous Thromboembolism Prophylaxis Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.5.4 Zenith Technical Innovations Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Zenith Technical Innovations Recent Developments
  • 11.6 Normatec
    • 11.6.1 Normatec Company Information
    • 11.6.2 Normatec Overview
    • 11.6.3 Normatec Venous Thromboembolism Prophylaxis Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.6.4 Normatec Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Normatec Recent Developments
  • 11.7 Bio Compression Systems
    • 11.7.1 Bio Compression Systems Company Information
    • 11.7.2 Bio Compression Systems Overview
    • 11.7.3 Bio Compression Systems Venous Thromboembolism Prophylaxis Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.7.4 Bio Compression Systems Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Bio Compression Systems Recent Developments
  • 11.8 ThermoTek USA
    • 11.8.1 ThermoTek USA Company Information
    • 11.8.2 ThermoTek USA Overview
    • 11.8.3 ThermoTek USA Venous Thromboembolism Prophylaxis Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.8.4 ThermoTek USA Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 ThermoTek USA Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Venous Thromboembolism Prophylaxis Industry Chain Analysis
  • 12.2 Venous Thromboembolism Prophylaxis Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Venous Thromboembolism Prophylaxis Production Mode & Process
  • 12.4 Venous Thromboembolism Prophylaxis Sales and Marketing
    • 12.4.1 Venous Thromboembolism Prophylaxis Sales Channels
    • 12.4.2 Venous Thromboembolism Prophylaxis Distributors
  • 12.5 Venous Thromboembolism Prophylaxis Customers

13 Market Dynamics

  • 13.1 Venous Thromboembolism Prophylaxis Industry Trends
  • 13.2 Venous Thromboembolism Prophylaxis Market Drivers
  • 13.3 Venous Thromboembolism Prophylaxis Market Challenges
  • 13.4 Venous Thromboembolism Prophylaxis Market Restraints

14 Key Findings in The Global Venous Thromboembolism Prophylaxis Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer